UNSPSC 85494212: Supplement mitral valve with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement mitral valve with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UG37Z

UNSPSC 85494212 Supplement mitral valve with autologous tissue substitute, percutaneous approach is a Commodity code that does not align with the recent state and local contract opportunities on record. The named opportunities—independent medical evaluation services for disability pension determinations, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty care for detained youth, pharmacy benefit management, and temporary health professional staffing—fall under healthcare administration, occupational health, and staffing services, not cardiac device procurement or implant-related work. The code's nominal scope describes a specific cardiovascular intervention, yet no state or local solicitation in the recent block seeks procurement of that device or related implant inventory.

State and local purchasing offices occasionally tag opportunities with codes that do not match the work being solicited. Without evidence of recent state or local opportunities for mitral valve supplements or percutaneous cardiac procedures under this code, activity cannot be characterized. Firms evaluating this Commodity code should verify whether their target jurisdictions use this code for cardiac device procurement at all, or confirm the correct taxonomy tier and code family through direct outreach to issuing procurement offices.